BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 9155961)

  • 1. A multicentre (double-blind) comparative study to assess the safety and efficacy of fluconazole and griseofulvin in the treatment of tinea corporis and tinea cruris.
    Faergemann J; Mörk NJ; Haglund A; Odegård T
    Br J Dermatol; 1997 Apr; 136(4):575-7. PubMed ID: 9155961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral treatment of tinea corporis and tinea cruris with terbinafine and griseofulvin: a randomized double blind comparative study.
    Voravutinon V
    J Med Assoc Thai; 1993 Jul; 76(7):388-93. PubMed ID: 8089640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial assessing the efficacy of fluconazole in the treatment of pediatric tinea capitis.
    Foster KW; Friedlander SF; Panzer H; Ghannoum MA; Elewski BE
    J Am Acad Dermatol; 2005 Nov; 53(5):798-809. PubMed ID: 16243128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study.
    Budimulja U; Bramono K; Urip KS; Basuki S; Widodo G; Rapatz G; Paul C
    Mycoses; 2001; 44(7-8):300-6. PubMed ID: 11714065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of itraconazole and griseofulvin in the treatment of tinea corporis and tinea cruris: a double-blind study.
    Panagiotidou D; Kousidou T; Chaidemenos G; Karakatsanis G; Kalogeropoulou A; Teknetzis A; Chatzopoulou E; Michailidis D
    J Int Med Res; 1992 Sep; 20(5):392-400. PubMed ID: 1333423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Itraconazole compared with griseofulvin in the treatment of tinea corporis/cruris and tinea pedis/manus: an interpretation of the clinical results of all completed double-blind studies with respect to the pharmacokinetic profile.
    Lachapelle JM; De Doncker P; Tennstedt D; Cauwenbergh G; Janssen PA
    Dermatology; 1992; 184(1):45-50. PubMed ID: 1313717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of topical griseofulvin in treatment of tinea corporis.
    Kassem MA; Esmat S; Bendas ER; El-Komy MH
    Mycoses; 2006 May; 49(3):232-5. PubMed ID: 16681816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study between terbinafine 1% emulsion-gel versus ketoconazole 2% cream in tinea cruris and tinea corporis.
    Bonifaz A; Saúl A
    Eur J Dermatol; 2000 Mar; 10(2):107-9. PubMed ID: 10694308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of a new oral antifungal, terbinafine, with griseofulvin as therapy for tinea corporis.
    Cole GW; Stricklin G
    Arch Dermatol; 1989 Nov; 125(11):1537-9. PubMed ID: 2684023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic options for the treatment of tinea capitis: griseofulvin versus fluconazole.
    Dastghaib L; Azizzadeh M; Jafari P
    J Dermatolog Treat; 2005 Feb; 16(1):43-6. PubMed ID: 15897167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of topical 1% butenafine and 1% clotrimazole in tinea cruris and tinea corporis: a randomized, double-blind trial.
    Singal A; Pandhi D; Agrawal S; Das S
    J Dermatolog Treat; 2005; 16(5-6):331-5. PubMed ID: 16428155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of terbinafine 1% solution in the treatment of interdigital tinea pedis and tinea corporis or tinea cruris.
    Lebwohl M; Elewski B; Eisen D; Savin RC
    Cutis; 2001 Mar; 67(3):261-6. PubMed ID: 11270304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative evaluation of fluconazole 50 mg and 100 mg versus itraconazole 100 mg in the treatment of dermatomycoses].
    Lospalluti M; Barile F; Pantaleo AK; Conese M; Guerra AP; Lo Re M; D'Amico G; Barbieri G
    Clin Ter; 1994 Feb; 144(2):129-38. PubMed ID: 8181207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative double-blind study of terbinafine (Lamisil) and griseofulvin in tinea corporis and tinea cruris.
    del Palacio Hernandez A; López Gómez S; González Lastra F; Moreno Palancar P; Iglesias Díez L
    Clin Exp Dermatol; 1990 May; 15(3):210-6. PubMed ID: 2194715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea corporis and tinea cruris.
    Bourlond A; Lachapelle JM; Aussems J; Boyden B; Campaert H; Conincx S; Decroix J; Geeraerts C; Ghekiere L; Morias J
    Int J Dermatol; 1989; 28(6):410-2. PubMed ID: 2548967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personal hygiene as an alternative to griseofulvin in the treatment of tinea cruris.
    Akinwale SO
    Afr J Med Med Sci; 2000 Mar; 29(1):41-3. PubMed ID: 11379466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluconazole in the treatment of tinea corporis and tinea cruris.
    Stary A; Sarnow E
    Dermatology; 1998; 196(2):237-41. PubMed ID: 9568414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double blind study of itraconazole vs griseofulvin in patients with tinea pedis and tinea manus.
    Wishart JM
    N Z Med J; 1994 Apr; 107(975):126-8. PubMed ID: 8145958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current treatment recommendations in tinea corporis?].
    Tietz HJ
    Med Monatsschr Pharm; 2006 Jul; 29(7):264-5. PubMed ID: 16866081
    [No Abstract]   [Full Text] [Related]  

  • 20. Once-weekly oral doses of fluconazole 150 mg in the treatment of tinea corporis/cruris and cutaneous candidiasis.
    Suchil P; Gei FM; Robles M; Perera-Ramírez A; Welsh O; Male O
    Clin Exp Dermatol; 1992 Nov; 17(6):397-401. PubMed ID: 1486705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.